Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Tobii AB Year-End Report 2017

Tobii AB today reported its results for the fourth quarter and full year 2017. Comment by Tobii’s CEO Henrik Eskilsson: “2017 was another eventful year for Tobii. Tobii Pro showed excellent performance, increasing sales on all fronts. Tobii Dynavox launched a large number of new products and recovered in the fourth quarter from the negative trend in the touch screen segment earlier in the year. In order to meet the rapid growth in demand for eye tracking in VR, Tobii Tech has established considerable operations in a short period of time and at year-end had collaborations with an

The Nomination Committee proposal to Swedbank AGM 2018

The Nomination Committee of Swedbank proposes election of Anna Mossberg as new Board member. Furthermore, the Nomination Committee proposes re-election of the present Board members Lars Idermark, Ulrika Francke, Siv Svensson, Bodil Eriksson, Peter Norman, Mats Granryd, Bo Johansson, Annika Poutiainen and Magnus Uggla, i.e. all present members are proposed for re-election. The proposal entails an increase of the number of Board members elected by the Annual General Meeting from nine to ten. Lars Idermark is proposed as Chair of the Board of Directors.The Nomination Committee proposes

THQ Nordic to Present its Year-End Report for 2017

THQ Nordic invites you to a live presentation of its report for the year ended 31 December 2017 on 14 February 2018, 09:00 (CET).  The event will be hosted by CEO Lars Wingefors and will be held in English. A question and answer session will immediately follow the presentation. The report will be published the same morning, well before the market opens.You are welcome to join the presentation in person or via telephone and web-cast. Date:         Wednesday, February 14, 2018 Time:         09:00 (CET) Place:        Carnegie Hall, Regeringsgatan 56, Stockholm Please register in

A record year for Platzer

·  Rental income increased to SEK 995 million (687)  ·  Income from property management improved by 51% to SEK 486 million (322)  ·  Profit for the period amounted to SEK 1,393 million (500)  ·  Property portfolio increased in value to SEK 15,559 million (13,615)  ·  Long-term net asset value (EPRA NAV) per share was SEK 58.39 (45.72)  ·  Earnings per share amounted to SEK 11.54 (4.92)   ·  The Board of Directors proposes a dividend of SEK 1.50 per share (1.10)  ·  Acquisition of Piren2 in Lindholmen  ·  Acquisition of 50% of the Merkur building in Skeppsbron  ·

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 8 February 2018 at 9.00 EETDuring the 1–31 January 2018 conversion period there was one conversion and a total of 400 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 8 February 2018, and trading in the new R shares will start on 9 February 2018.Breakdown of shares after conversion: A shares  176 351 210R shares  612 268 777Total  788 619 987 Each A share and each ten R shares carry one vote. The total amount of votes after the conversion is at least 237 578 087.For further

Vicore Pharma acquires shares in I-Tech

Vicore Pharma Holding AB (publ) (ticker: VICO) announces a share increase in I-Tech AB.Vicore Pharma Holding AB has acquired shares in I-Tech AB from an existing shareholder with long ownership history in the company. Vicore Pharma Holding holds 26.5% of the shares in I-Tech which is an increase from previous 21% ownership after the acquisition. All issued shares were acquired by current shareholders in I-Tech in accordance with a pre-emption procedure. "We have further increased our holding in I-Tech. We participated in a share issue in the end of 2017 and have in addition acquired

PowerCell participates in EU project to reduce the cost of hydrogen as fuel

The EU has decided to approve the project HYDRAITE to develop technology to reduce the cost of hydrogen. PowerCell Sweden AB (publ) supplies the project with fuel cell stacks and contributes with expert competence.The HYDRAITE project is initiated as a response to the European industry's need to reduce the cost of the quality assurance of fuel and thus the cost of hydrogen. The purpose of the project is to study contaminants that arise in the hydrogen supply chain, including contaminants from hydrogen fueling stations, and how this affects the quality of hydrogen. Another goal is to better

Veidekke ASA: Key information relating to the cash dividend to be paid by Veidekke ASA

The Board of Directors has decided to propose for the annual general meeting a dividend for fiscal year 2017 of NOK 5.00 per share. Dividend amount: 5.00 per share Declared currency: Norwegian Krone Last day including right: 2 May 2018 Ex-date: 3 May 2018 Record date: 4 May 2018 Payment date: 16 May 2018 Date of approval: 2 May 2018 Contact:Jørgen G. MicheletHead of Investor RelationsPhone: +47 917 43 856 This information is published in accordance with the requirements of the Continuing Obligations This information is subject to the disclosure

INVITATION TO Q4 2017 PRESENTATION

Techstep ASA will release its fourth quarter results on Thursday 15 February 2018 at 7.00 am CET. The quarterly report and presentation will be made available on the company’s website www.techstepasa.no and www.newsweb.no. CEO Gaute Engbakk and CFO Marius Drefvelin will present the company’s results at 10:00 am CET at Arctic Securities, Haakon VII’s gate 5, in Oslo. The presentation will be given in Norwegian, with supporting material in English. The presentation can also be followed through live audio webcast. Webcast – audio and slide presentationPlease join the Q4 2017 results

Aker Solutions Wins Services Contract from Petrobras in Brazil

February 8, 2018 - Aker Solutions won a contract to provide maintenance and modifications services for three platforms at Petrobras-operated oil and gas fields offshore Brazil, expanding its business in a key international market. The four-year contract is valued at about NOK 800 million and includes an option for a one-year extension.  The order covers a range of services to renovate, repair and upgrade the floating production storage and offloading platforms, or FPSOs, at the Barracuda, Caratinga and Albacora Leste fields in the Campos Basin. It also entails management at the yard

Konecranes Plc Financial Statement Release 2017

KONECRANES PLC FINANCIAL STATEMENT RELEASE February 8, 2018 at 09.00 EET ADJUSTED EBITA IMPROVED IN 2017, SUCCESSFUL YEAR OF INTEGRATION This release is a summary of Konecranes Plc’s Financial Statement Release 2017. The complete report is attached to this release in pdf format and is also available on Konecranes’ website at www.konecranes.com. Figures in brackets, unless otherwise stated, refer to the same period a year earlier. FOURTH QUARTER HIGHLIGHTS (COMPARISON TO COMBINED COMPANY FIGURES*) - Order intake EUR 732.6 million (921.5), -20.5 percent- Order book EUR 1,535.

Herantis Pharma completes patient enrolment in Phase 1 study of Lymfactin gene therapy for secondary lymphedema and has submitted Phase 2 application

Herantis Pharma completes patient enrolment in Phase 1 study of Lymfactin gene therapy for secondary lymphedema and has submitted Phase 2 application Herantis Pharma PlcCompany release 8 Feb 2018 at 9:00 am Herantis Pharma Plc ("Herantis") has completed the patient enrolment in the clinical Phase 1 safety and tolerability study with the company's investigational gene therapy product Lymfactin® for the treatment of breast cancer associated secondary lymphedema. The company intends to proceed rapidly to a randomized, placebo-controlled Phase 2 study of Lymfactin® in the same

Sweco strengthens its position within European hospital design

Sweco has been commissioned for three new hospital projects in Belgium, Germany and Norway. Sweco’s combined experience and competence within hospitals have been key when winning these projects. The company’s experts will advise in architectural as well as technical matters. The overall result will be hospitals that meet both today’s high standards and tomorrow’s demands for patient security and modern technology.“Sweco has a long and successful history of healthcare projects throughout Europe which is one of the key reasons why Sweco won these projects. Sweco’s previous knowledge and

Read original

Record output from Vattenfall’s nuclear power

In 2017, Vattenfall’s nuclear power plants at Forsmark and Ringhals accounted for a third of Swedish electricity production. With an output of 52 billion kWh from these two power plants, 2017 was the third best year since the first reactor began operations 42 years ago.“Ever since the first reactor at Ringhals was taken into operation in 1976, Vattenfall’s nuclear power plants have produced 1,638 TWh.That corresponds to the total electricity demand for Sweden for a period of twelve years  and with a very low climate impact,” says Torbjörn Wahlborg, Senior Vice President and Head of Business

Lindab International AB (publ): Lindab's Report for the Fourth Quarter and Full Year 2017

8 February 2018 Fourth Quarter 2017   · Net sales increased by 7 percent to SEK 2,185 m (2,039), of which organic growth amounted to 7 percent. · Adjusted1) operating profit increased by 6 percent to SEK 119 m (112). Operating profit amounted to SEK 109 m (112). · Adjusted1) operating margin amounted to 5.4 percent (5.5). · Profit for the period rose by 6 percent to SEK 84 m (79). · Earnings per share, before and after dilution, increased to SEK 1.10 (1.04). · Cash flow from operating activities amounted to SEK 346 m (265). · In December, the Irish

ICA Gruppen’s sustainability report for fourth quarter 2017

Driving For A Good Tomorrow with focus on health and climate is one of ICA Gruppen’s strategic priorities for 2018 that was set during the fourth quarter of 2017.“We will further increase our efforts in 2018. Our strategic priorities for the year include driving For A Good Tomorrow with focus on health and climate. We will continue the work on lowering our own carbon footprint, not least through continued investments in renewable energy and a gradual changeover to refrigerants with a lower carbon footprint. We will also channel even more energy into inspiring our customers to make

YEAR-END REPORT NORDAX GROUP AB 2017

JANUARY-DECEMBER 2017 Numbers compared to January-December 2016 · The loan portfolio grew by 5%, in constant currencies by 7% · The net interest margin decreased to 9.1% (9.3%) · Total operating income increased to 1,189 MSEK (1,176). Adjusted total operating income increased to 1,207 MSEK (1,113) · Adjusted cost to income ratio (rolling 12 months) improved to 25.8% (27.3%) · Operating profit decreased to 529 MSEK (573). Adjusted operating profit increased by 10% to 559 MSEK (510) · Net profit decreased to 409 MSEK (446) · Earnings per share were 3.69 SEK (4.02).

Teleste´s Financial Statements 2017: Net sales and result decreased in 2017, record-level order backlog

TELESTE CORPORATION    FINANCIAL STATEMENTS  8.2.2018  AT 08:30 (a.m. EET)                                                            FINANCIAL STATEMENTS OF TELESTE CORPORATION 1 JANUARY TO 31 DECEMBER 2017 NET SALES AND RESULT DECREASED IN 2017, RECORD-LEVEL ORDER BACKLOG   Fourth quarter of 2017 – Net sales amounted to EUR 58.7 (68.6) million, a decrease of 14.4%– Operating result stood at EUR 0.3 (4.3) million, a decrease of 94.1%. The operating result includes a personnel reduction-related restructuring provision of EUR 0.8 million.– Undiluted earnings per share

Statement by the Board of Directors of Nordax in relation to the mandatory public offer from Nordic Capital and Sampo and postponement of the 2018 AGM

The Board of Directors of Nordax unanimously recommends the shareholders in Nordax to accept the mandatory public cash offer from Nordic Capital and Sampo.This statement is made by the Board of Directors of Nordax Group AB (“Nordax” or the “Company”) pursuant to Rule II.19 of Nasdaq Stockholm’s Takeover Rules (the “Takeover Rules”). Background Today on 8 February 2018, Nordic Capital Fund VIII (“Nordic Capital”) and Sampo plc (“Sampo”), through NDX Intressenter AB (“NDX Intressenter”) announced a mandatory public cash offer to the shareholders of Nordax to sell all of their shares to

Annual Statement 2017

A strong year  Fourth quarter 2017 ·  Revenue in the fourth quarter was SEK 152.7 (135.7) million, equivalent to a 13 percent increase. ·  Operating profit excluding non-recurring costs for the fourth quarter increased to SEK 40.6 (34.6) million, corresponding to an operating margin excluding non-recurring costs of 26.6 (25.5)   percent. ·  Operating profit for the fourth quarter decreased to SEK 23.5 (33.5) million, equivalent to an operating margin of 15.4 (24.7) percent. ·  Earnings per share decreased to SEK 0.97 (1.67) for the fourth quarter. ·  Cash flow from

Nordic Capital launches a joint recommended mandatory cash offer to the shareholders in Nordax

Nordic Capital Fund VIII (“Nordic Capital”) and Sampo plc (“Sampo”), through NDX Intressenter AB (“NDX Intressenter”), today announced a recommended public cash offer to the shareholders in Nordax Group AB (publ) (“Nordax”) to acquire all outstanding shares in Nordax at a price of SEK 60 per share (the “Offer”).The Board of Directors in Nordax unanimously recommends the Offer for acceptance by the shareholders in Nordax. The Offer represents a premium of 34.5 per cent to the closing price of SEK 44.6 for the Nordax share on 11 October, 2017, the last trading day before the announcement

Massachusetts General Hospital joins PanFAM-1 prospective study for the early detection of pancreatic cancer in familiar risk groups

Forming collaborations and establishing a presence in the USA is central to Immunovia’s reimbursement strategy and market introduction. The continued expansion of PanFAM-1 into the largest ever prospective multicenter study for early detection of pancreatic cancer is another vital step towards these goals.  The participation of the prestigious MassGen will strengthen the study, which is designed to validate IMMrayTM PanCan-d, Immunovia´s blood-based test for early detection of pancreatic cancerLUND, Sweden, and Boston, USA ― Immunovia AB today announced that Massachusetts General Hospital

ICA stores – January sales figures

Sales in ICA stores increased by 2.8% in January 2018 compared with the corresponding month last year. Sales in like-for-like stores increased by 2.4%.+--------------------+-----+-----------------+--------------------+| | January 2018 |+--------------------+-----+-----------------+--------------------+|Store sales | Mkr|Change all stores|Change like-for-like||excl. VAT | | | |+--------------------+-----+-----------------+--------------------+|Maxi ICA Stormarknad|2,752|

ICA to open dark store

ICA Sweden will begin offering a central solution for picking and fulfilling e-commerce orders by the third quarter of 2018 at the latest. Central order picking will improve delivery times for customers who want home delivery, and the warehouse will be able to serve a large part of the Mälardalen area once fully staffed. ICA will begin central picking from existing premises in Johanneshov, Stockholm.E-commerce is beginning to account for a significant share of sales for many ICA stores, and many of these do not have the capacity to fulfil e-commerce orders from their stores. To increase

There are no items matching the current filter
There are no more items matching the current filter
Back to top